NEWTEKONE INC - NEWT 8 09/01/28 (NEWTI) Fundamental Analysis & Valuation

NASDAQ:NEWTI • US6525268073

Current stock price

25.12 USD
+0.09 (+0.36%)
Last:

This NEWTI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. NEWTI Profitability Analysis

1.1 Basic Checks

  • NEWTI had positive earnings in the past year.
  • NEWTI had a negative operating cash flow in the past year.
  • In the past 5 years NEWTI has always been profitable.
  • NEWTI had negative operating cash flow in 4 of the past 5 years.
NEWTI Yearly Net Income VS EBIT VS OCF VS FCFNEWTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M

1.2 Ratios

  • With a Return On Assets value of 2.12%, NEWTI perfoms like the industry average, outperforming 59.00% of the companies in the same industry.
  • NEWTI has a better Return On Equity (14.63%) than 74.00% of its industry peers.
  • NEWTI has a Return On Invested Capital (4.06%) which is comparable to the rest of the industry.
  • NEWTI had an Average Return On Invested Capital over the past 3 years of 3.79%. This is below the industry average of 8.10%.
  • The last Return On Invested Capital (4.06%) for NEWTI is above the 3 year average (3.79%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.12%
ROE 14.63%
ROIC 4.06%
ROA(3y)2.57%
ROA(5y)3.78%
ROE(3y)16.56%
ROE(5y)15.82%
ROIC(3y)3.79%
ROIC(5y)5.19%
NEWTI Yearly ROA, ROE, ROICNEWTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 18.80%, NEWTI is in the better half of the industry, outperforming 78.00% of the companies in the same industry.
  • NEWTI's Profit Margin has declined in the last couple of years.
  • NEWTI has a better Operating Margin (46.39%) than 83.00% of its industry peers.
  • In the last couple of years the Operating Margin of NEWTI has declined.
  • NEWTI has a Gross Margin of 94.25%. This is amongst the best in the industry. NEWTI outperforms 96.00% of its industry peers.
Industry RankSector Rank
OM 46.39%
PM (TTM) 18.8%
GM 94.25%
OM growth 3Y-4.87%
OM growth 5Y-4.75%
PM growth 3Y-5.91%
PM growth 5Y-10.33%
GM growth 3YN/A
GM growth 5YN/A
NEWTI Yearly Profit, Operating, Gross MarginsNEWTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. NEWTI Health Analysis

2.1 Basic Checks

  • NEWTI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for NEWTI has been increased compared to 1 year ago.
  • Compared to 5 years ago, NEWTI has more shares outstanding
  • Compared to 1 year ago, NEWTI has about the same debt to assets ratio.
NEWTI Yearly Shares OutstandingNEWTI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
NEWTI Yearly Total Debt VS Total AssetsNEWTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • Based on the Altman-Z score of -0.01, we must say that NEWTI is in the distress zone and has some risk of bankruptcy.
  • NEWTI has a worse Altman-Z score (-0.01) than 61.00% of its industry peers.
  • A Debt/Equity ratio of 5.63 is on the high side and indicates that NEWTI has dependencies on debt financing.
  • The Debt to Equity ratio of NEWTI (5.63) is worse than 81.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.63
Debt/FCF N/A
Altman-Z -0.01
ROIC/WACC0.63
WACC6.43%
NEWTI Yearly LT Debt VS Equity VS FCFNEWTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M

2.3 Liquidity

  • NEWTI has a Current Ratio of 0.19. This is a bad value and indicates that NEWTI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NEWTI has a worse Current ratio (0.19) than 69.00% of its industry peers.
  • A Quick Ratio of 0.19 indicates that NEWTI may have some problems paying its short term obligations.
  • NEWTI has a Quick ratio of 0.19. This is in the lower half of the industry: NEWTI underperforms 69.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.19
NEWTI Yearly Current Assets VS Current LiabilitesNEWTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. NEWTI Growth Analysis

3.1 Past

  • The earnings per share for NEWTI have decreased strongly by -50.26% in the last year.
  • Measured over the past years, NEWTI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.98% on average per year.
  • The Revenue has grown by 13.34% in the past year. This is quite good.
  • Measured over the past years, NEWTI shows a very strong growth in Revenue. The Revenue has been growing by 24.47% on average per year.
EPS 1Y (TTM)-50.26%
EPS 3Y-23.3%
EPS 5Y-13.98%
EPS Q2Q%-5.8%
Revenue 1Y (TTM)13.34%
Revenue growth 3Y29.32%
Revenue growth 5Y24.47%
Sales Q2Q%-4.6%

3.2 Future

  • Based on estimates for the next years, NEWTI will show a very strong growth in Earnings Per Share. The EPS will grow by 46.82% on average per year.
  • NEWTI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.39% yearly.
EPS Next Y144.13%
EPS Next 2Y61.36%
EPS Next 3Y46.82%
EPS Next 5YN/A
Revenue Next Year14.33%
Revenue Next 2Y13.39%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
NEWTI Yearly Revenue VS EstimatesNEWTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
NEWTI Yearly EPS VS EstimatesNEWTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

4

4. NEWTI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 25.90, NEWTI can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, NEWTI is valued a bit more expensive than 62.00% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of NEWTI to the average of the S&P500 Index (26.78), we can say NEWTI is valued inline with the index average.
  • The Price/Forward Earnings ratio is 10.61, which indicates a very decent valuation of NEWTI.
  • NEWTI's Price/Forward Earnings is on the same level as the industry average.
  • NEWTI is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.54, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.9
Fwd PE 10.61
NEWTI Price Earnings VS Forward Price EarningsNEWTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NEWTI is valued a bit cheaper than 69.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.06
NEWTI Per share dataNEWTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10

4.3 Compensation for Growth

  • NEWTI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • NEWTI's earnings are expected to grow with 46.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.18
PEG (5Y)N/A
EPS Next 2Y61.36%
EPS Next 3Y46.82%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. NEWTI Dividend Analysis

5.1 Amount

  • NEWTI has a Yearly Dividend Yield of 7.27%, which is a nice return.
  • Compared to an average industry Dividend Yield of 2.20, NEWTI pays a better dividend. On top of this NEWTI pays more dividend than 94.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, NEWTI pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.27%

5.2 History

  • The dividend of NEWTI decreases each year by -12.63%.
  • NEWTI has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)-12.63%
Div Incr Years0
Div Non Decr Years2
NEWTI Yearly Dividends per shareNEWTI Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • NEWTI pays out 48.20% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP48.2%
EPS Next 2Y61.36%
EPS Next 3Y46.82%
NEWTI Yearly Income VS Free CF VS DividendNEWTI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M
NEWTI Dividend Payout.NEWTI Dividend Payout, showing the Payout Ratio.NEWTI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NEWTI Fundamentals: All Metrics, Ratios and Statistics

NEWTEKONE INC - NEWT 8 09/01/28

NASDAQ:NEWTI (4/10/2026, 8:00:01 PM)

25.12

+0.09 (+0.36%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)01-29
Earnings (Next)04-30
Inst Owners44.05%
Inst Owner ChangeN/A
Ins Owners6.08%
Ins Owner ChangeN/A
Market Cap774.45M
Revenue(TTM)309.46M
Net Income(TTM)58.18M
Analysts73.85
Price Target35.76 (42.36%)
Short Float %0.02%
Short Ratio1.04
Dividend
Industry RankSector Rank
Dividend Yield 7.27%
Yearly Dividend1.02
Dividend Growth(5Y)-12.63%
DP48.2%
Div Incr Years0
Div Non Decr Years2
Ex-Date02-27
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.13%
Min EPS beat(2)-6.52%
Max EPS beat(2)2.25%
EPS beat(4)1
Avg EPS beat(4)-59.57%
Min EPS beat(4)-230.76%
Max EPS beat(4)2.25%
EPS beat(8)5
Avg EPS beat(8)-22.65%
EPS beat(12)7
Avg EPS beat(12)-14.64%
EPS beat(16)9
Avg EPS beat(16)-15.55%
Revenue beat(2)0
Avg Revenue beat(2)-8.96%
Min Revenue beat(2)-10.14%
Max Revenue beat(2)-7.77%
Revenue beat(4)1
Avg Revenue beat(4)-2.02%
Min Revenue beat(4)-10.14%
Max Revenue beat(4)16.67%
Revenue beat(8)5
Avg Revenue beat(8)2.8%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)12.69%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.91%
EPS NY rev (1m)0%
EPS NY rev (3m)3.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.61%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.54%
Valuation
Industry RankSector Rank
PE 25.9
Fwd PE 10.61
P/S 2.5
P/FCF N/A
P/OCF N/A
P/B 1.95
P/tB 2.02
EV/EBITDA 9.06
EPS(TTM)0.97
EY3.86%
EPS(NY)2.37
Fwd EY9.43%
FCF(TTM)-19.12
FCFYN/A
OCF(TTM)-18.79
OCFYN/A
SpS10.04
BVpS12.9
TBVpS12.42
PEG (NY)0.18
PEG (5Y)N/A
Graham Number16.78
Profitability
Industry RankSector Rank
ROA 2.12%
ROE 14.63%
ROCE 11.69%
ROIC 4.06%
ROICexc 4.55%
ROICexgc 5.05%
OM 46.39%
PM (TTM) 18.8%
GM 94.25%
FCFM N/A
ROA(3y)2.57%
ROA(5y)3.78%
ROE(3y)16.56%
ROE(5y)15.82%
ROIC(3y)3.79%
ROIC(5y)5.19%
ROICexc(3y)4.39%
ROICexc(5y)5.63%
ROICexgc(3y)4.84%
ROICexgc(5y)7.65%
ROCE(3y)9.67%
ROCE(5y)9.69%
ROICexgc growth 3Y-22.07%
ROICexgc growth 5Y-10.94%
ROICexc growth 3Y-11.48%
ROICexc growth 5Y-4.52%
OM growth 3Y-4.87%
OM growth 5Y-4.75%
PM growth 3Y-5.91%
PM growth 5Y-10.33%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 5.63
Debt/FCF N/A
Debt/EBITDA 15.52
Cap/Depr 1530.84%
Cap/Sales 3.3%
Interest Coverage 1.47
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.19
Altman-Z -0.01
F-Score3
WACC6.43%
ROIC/WACC0.63
Cap/Depr(3y)523.78%
Cap/Depr(5y)314.27%
Cap/Sales(3y)1.23%
Cap/Sales(5y)0.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50.26%
EPS 3Y-23.3%
EPS 5Y-13.98%
EPS Q2Q%-5.8%
EPS Next Y144.13%
EPS Next 2Y61.36%
EPS Next 3Y46.82%
EPS Next 5YN/A
Revenue 1Y (TTM)13.34%
Revenue growth 3Y29.32%
Revenue growth 5Y24.47%
Sales Q2Q%-4.6%
Revenue Next Year14.33%
Revenue Next 2Y13.39%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y30.11%
EBIT growth 3Y23.02%
EBIT growth 5Y18.55%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-280.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-274.97%
OCF growth 3YN/A
OCF growth 5YN/A

NEWTEKONE INC - NEWT 8 09/01/28 / NEWTI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for NEWTEKONE INC - NEWT 8 09/01/28?

ChartMill assigns a fundamental rating of 4 / 10 to NEWTI.


What is the valuation status of NEWTEKONE INC - NEWT 8 09/01/28 (NEWTI) stock?

ChartMill assigns a valuation rating of 4 / 10 to NEWTEKONE INC - NEWT 8 09/01/28 (NEWTI). This can be considered as Fairly Valued.


What is the profitability of NEWTI stock?

NEWTEKONE INC - NEWT 8 09/01/28 (NEWTI) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for NEWTI stock?

The Price/Earnings (PE) ratio for NEWTEKONE INC - NEWT 8 09/01/28 (NEWTI) is 25.9 and the Price/Book (PB) ratio is 1.95.


How financially healthy is NEWTEKONE INC - NEWT 8 09/01/28?

The financial health rating of NEWTEKONE INC - NEWT 8 09/01/28 (NEWTI) is 0 / 10.